Loading…
Loading…
EQUITY / NASDAQ · XNCM
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Following is saved. Automatic company research is not available for this coverage; explore the evidence with Research.
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →04/01/2026 – 06/30/2026 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗4.47 USD
Observed: 10/02/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/02/2026 · 4.47 USD · Volume 20,300
64 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
8 available financial reports
Research reports →SEC FINANCIAL REPORTS
04/01/2026 – 06/30/2026 · Units
| Metric | 2026 / Quarter 2 | 2025 / Quarter 2 | Change |
|---|---|---|---|
| Net income | -5,371,042 USD | -3,695,938 USD | — |
| Cash and cash equivalents | 3,845,606 USD | — | — |
| Total liabilities | 8,036,891 USD | — | — |
| Total equity | 3,932,671 USD | 2,551,357 USD | +54.14% |
| Total assets | 11,969,562 USD | — | — |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2026 / Quarter 204/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 06/30/2026ConsolidatedUnits · USD | 2026 / Quarter 201/01/2026 – 03/31/2026ConsolidatedUnits · USD | 2025 / Quarter 212/31/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Year end01/01/2025 – 12/31/2025ConsolidatedUnits · USD | 2025 / Quarter 307/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 301/01/2025 – 09/30/2025ConsolidatedUnits · USD | 2025 / Quarter 204/01/2025 – 06/30/2025ConsolidatedUnits · USD |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 3,845,606 USD | — | — | 3,818,096 USD | 3,818,096 USD | 1,830,906 USD | — | — |
| Net incomeIncome statement | -5,371,042 USD | -10,368,777 USD | -4,997,735 USD | — | -15,804,655 USD | -3,948,165 USD | -11,456,282 USD | -3,695,938 USD |
| Total assetsBalance sheet | 11,969,562 USD | — | — | 20,390,569 USD | 20,390,569 USD | 6,423,664 USD | — | — |
| Total equityBalance sheet | 3,932,671 USD | — | 8,773,132 USD | 13,119,906 USD | 13,119,906 USD | -1,214,620 USD | — | 2,551,357 USD |
| Total liabilitiesBalance sheet | 8,036,891 USD | — | — | 7,270,663 USD | 7,270,663 USD | 7,638,284 USD | — | — |
| Financing cash flowCash flow statement | — | -95,965 USD | — | — | 18,014,135 USD | — | -277,042 USD | — |
| Investing cash flowCash flow statement | — | 8,136,707 USD | — | — | -4,277,775 USD | — | 6,990,574 USD | — |
| Operating cash flowCash flow statement | — | -8,013,263 USD | — | — | -13,540,994 USD | — | -8,505,969 USD | — |
| Report source | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 08/14/2026 | Open report ↗ Published: 03/26/2026 | Open report ↗ Published: 11/06/2025 | Open report ↗ Published: 11/06/2025 | Open report ↗ Published: 08/14/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.